Why it’s okay for Rolling Stone to write false stories about a drug called Ivermectin

Barry Arrington wrote an interesting post on Rolling Stone’s latest debacle: Ridiculous claims about Ivermectin overdoses.

Followed up at the page by commenters discussing the earlier self-satisfied media claims that the Wuhan lab leak was a crackpot theory.

The Wuhan lab leak is today’s Chernobyl.

It’s all a perfect illustration of what sold-out media incompetence can do.

Readers, they don’t need you. And you don’t need them. We all have the internet.

Ivermectin probably usually works, used as directed. Whether that is convenient to Big Pharma or not. Something happened at the Wuhan Level 4 virus lab. Whether that is convenient to the Chinese Communist Party or not.

But much that happens in media today is not about what happened. It’s about Hot Hair and Big Lipstick posing as news.

One thing to see is that Big Media wants the Chinese market, which it can only get by telling people the stories the CCP wants them to hear.

Increasingly, more and more of the real stories will be provided by independent media. We are more important than we ever used to be. – Denyse O’Leary

See also: Update on COVID-19 origins In January, Dr. Peter Ben Embarek said it was “extremely unlikely” that COVID-19 came from a lab accident. He has since begun to walk back those claims.

And any story from Uncommon Descent

Copyright © 2021 Uncommon Descent . This Feed is for personal non-commercial use only. If you are not reading this material in your news aggregator, the site you are looking at is guilty of copyright infringement UNLESS EXPLICIT PERMISSION OTHERWISE HAS BEEN GIVEN. Please contact legal@uncommondescent.com so we can take legal action immediately.
Plugin by Taragana
 •  0 comments  •  flag
Share on Twitter
Published on September 08, 2021 09:28
No comments have been added yet.


Michael J. Behe's Blog

Michael J. Behe
Michael J. Behe isn't a Goodreads Author (yet), but they do have a blog, so here are some recent posts imported from their feed.
Follow Michael J. Behe's blog with rss.